Troy Edward Wilson, Director at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 27,000 shares at $3.45 ($93K) on 2023-06-13, disclosed to the SEC on 2023-06-15.
Scheduled sale ($93k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KURA | BUY | 2026-08-17 | $1.1M | — | Filing → |
| PBYI | SELL | 2026-06-15 | $78K | — | Filing → |
| KURA | SELL | 2025-09-29 | $655K | — | Filing → |